Skip to content
  • Sunday, 16 August 2026
  • 5:25 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 19, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating a period of unprecedented expansion, marked by…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 11, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently executing a monumental expansion strategy, with approximately $7…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 4, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating an unprecedented phase of strategic expansion, marked…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jun 27, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently experiencing an unprecedented period of expansion, marked by…

Read More
Unveiling Earth’s Hidden Arteries: First Global Maps Reveal 110 Quadrillion Kilometers of Vital Fungal NetworksInnovations in AI, Data Science, and Python Architecture Dominate Mid-July 2026 DiscussionsPrecision Synthesis Method Unlocks Unprecedented Electrical Performance in MXene Nanomaterials through Atomic Surface ControlArtificial Heart Patients Exhibit Potential for Heart Muscle Regeneration Offering New Hope for Heart Failure Treatment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ